Related Experiment Video

Updated: Aug 24, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

[The future has already begun. Molecular oncology of prostatic carcinoma]

J E Gschwend, J Noldus

    Der Urologe. Ausg. A
    |April 21, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An Orthotopic Murine Model of Human Prostate Cancer Metastasis
    06:48

    An Orthotopic Murine Model of Human Prostate Cancer Metastasis

    Published on: September 18, 2013

    Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
    07:01

    Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

    Published on: August 29, 2016

    Related Experiment Videos

    Last Updated: Aug 24, 2026

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
    13:19

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

    Published on: November 2, 2013

    An Orthotopic Murine Model of Human Prostate Cancer Metastasis
    06:48

    An Orthotopic Murine Model of Human Prostate Cancer Metastasis

    Published on: September 18, 2013

    Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
    07:01

    Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

    Published on: August 29, 2016

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

    Articles linked to this work by shared authors, journal, and citation graph.

    Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025

    Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2023

    [Value of immunotherapy in the perioperative treatment of localized muscle invasive bladder cancer].

    Urologie (Heidelberg, Germany)·2022

    [Quality assurance for the treatment of muscle-invasive and metastasized bladder carcinoma in Germany : An initiative of the Working Groups Urological Oncology (AUO) and Internal Oncology (AIO) in the German Cancer Society (DKG)].

    Urologie (Heidelberg, Germany)·2022

    [Early cystectomy-patient selection and technique].

    Der Urologe. Ausg. A·2021

    [Quality assessment of radical cystectomy-opportunities, risks, challenges].

    Der Urologe. Ausg. A·2021

    [G-CSF for prophylaxis of neutropenia and febrile neutropenia, anemia in cancer : Guidelines on supportive treatment part 1].

    Der Urologe. Ausg. A·2022

    [Multiparametric MRI of the prostate].

    Der Urologe. Ausg. A·2022

    [Follow-up in superficial and metastatic bladder cancer].

    Der Urologe. Ausg. A·2022

    [Follow-up after urolithiasis management].

    Der Urologe. Ausg. A·2022

    [Aftercare and adjuvant therapy for advanced renal cell carcinoma].

    Der Urologe. Ausg. A·2022

    A single-center retrospective study evaluating the efficacy of anlotinib plus temozolomide for recurrent glioma based on real-world data.

    Translational cancer research·2026

    Mechanism of miR-188-5p enhancing radioresistance in nasopharyngeal carcinoma by targeting PTEN to activate the PI3K/Akt signaling pathway.

    Translational cancer research·2026

    A real-world feasibility and safety study of anlotinib monotherapy in heavily pretreated or temozolomide-ineligible recurrent malignant glioma.

    Translational cancer research·2026

    Remodeling the tumor immune microenvironment: mechanisms of crosstalk between regulated cell death macrophages.

    Frontiers in immunology·2026

    Stem cell-derived exosomes preserve diabetic islet function: a systematic review and meta-analysis of preclinical studies.

    Biophysics reports·2026

    Pathological role of deubiquitinating enzymes in lung cancer: recent insights and advances.

    American journal of cancer research·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us